FCPM III SERVICES B.V. Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$500.4B
Holdings
9
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (9 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NAMSNEWAMSTERDAM PHARMA COMPANY | 9,212,384 | $262.0B | 52.36% | |
| 2 | DYNDYNE THERAPEUTICS INC | 5,462,846 | $69.1B | 13.81% | |
| 3 | ENGNENGENE HOLDINGS INC | 9,632,561 | $65.8B | 13.15% | |
| 4 | CATBUSDASTRIA THERAPEUTICS INC | 4,107,537 | $29.9B | 5.98% | |
| 5 | BCYCBICYCLE THERAPEUTICS PLC | 3,452,330 | $26.7B | 5.34% | |
| 6 | VORVOR BIOPHARMA INC | 379,640 | $18.5B | 3.70% | |
| 7 | REPLREPLIMUNE GROUP INC | 4,158,368 | $17.4B | 3.48% | |
| 8 | RAPTRAPT THERAPEUTICS INC | 344,237 | $8.9B | 1.77% | |
| 9 | ENGNWENGENE HOLDINGS INC | 2,878,148 | $2.1B | 0.41% |